This federal contract was awarded by the Defense Health Agency (DHA) to Siemens Healthcare Diagnostics Inc., a for-profit manufacturer, for the provision of REAGENTS. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, with a ceiling value of $500,000.00 and a period of performance ending on September 7, 2017. The contract does not have a set-aside designation. Siemens Healthcare Diagnostics Inc. is the prime contractor, and its parent company is Siemens...
This is a Blanket Purchase Agreement (BPA) call award by the Defense Health Agency (DHA) to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft (Siemens AG), for $550,000.00. The award is for reagents and peripherals consumables, which supports clinical laboratory testing services and associated equipment and supplies. The contract does not have a set-aside designation. Siemens Healthcare Diagnostics Inc. is a major provider of clinical diagnostic testing capabilities...
This is a federal contract award to Siemens Healthcare Diagnostics Inc., a wholly-owned subsidiary of Siemens Aktiengesellschaft (Siemens AG), a global technology conglomerate. The contract, with a ceiling value of $99,778.29, was awarded by the Defense Health Agency (DHA) under a Blanket Purchase Agreement (BPA) for the purchase of reagents and related items. The contract is a Firm Fixed Price (FFP) contract with no set-aside designation. Siemens Healthcare Diagnostics Inc. is a major...
This is a federal contract award to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, by the Defense Health Agency. The contract, valued at $2,752.14, is for the provision of consumable reagents. It is a Blanket Purchase Agreement (BPA) call order with a firm fixed price. The award does not utilize any set-aside designations, indicating Siemens Healthcare Diagnostics Inc. competed for the contract on a full and open basis. Siemens Healthcare Diagnostics Inc. is a...
This is a firm-fixed price Blanket Purchase Agreement (BPA) call order awarded by the Defense Health Agency to Siemens Healthcare Diagnostics Inc., a for-profit manufacturer of medical testing equipment, reagents, and supplies. The $195,393.93 contract is for the provision of reagents and peripheral consumables in support of the agency's clinical testing capabilities. The award does not have a set-aside designation. Siemens Healthcare Diagnostics Inc. is a subsidiary of the larger parent company...
Siemens Healthcare Diagnostics Inc., a division of Siemens Aktiengesellschaft, has been awarded a blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide reagents. Valued at approximately $57,000, the firm fixed price contract runs through July 2023 and does not have a set-aside designation. As the healthcare component of the U.S. Department of Defense, the Defense Health Agency manages a global health care system serving over 9.6 million beneficiaries. This...
This federal contract award to Siemens Healthcare Diagnostics Inc. is for the provision of REAGENTS. The $95,539.89 firm fixed price contract was issued by the Bureau of Medicine and Surgery, which is part of the Department of Defense. The contract is a Blanket Purchase Agreement (BPA) call order with no set-aside designation. Siemens Healthcare Diagnostics Inc. is a for-profit manufacturer of medical testing equipment, reagents, and supplies that has received multiple prior federal contract...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, a global technology company. The $13,845.95 award is for the delivery of consumable laboratory supplies to support clinical testing operations at government medical facilities. This contract award is not set aside for any specific business type. Siemens Healthcare Diagnostics Inc. holds multiple...
Siemens Healthcare Diagnostics Inc., a division of Siemens Aktiengesellschaft, has been awarded a $57,000 firm fixed price blanket purchase agreement call contract by the Defense Health Agency to provide reagents and supplies. The contract does not have any set aside designations and runs through June 30th, 2022. Siemens Healthcare Diagnostics will deliver the requested laboratory reagents and supplies to support the Defense Health Agency's medical testing and diagnostic programs. Performance...
Siemens Healthcare Diagnostics Inc. was awarded a $57,000 blanket purchase agreement call contract by the Defense Health Agency to provide clinical chemistry assays reagents. Under this firm fixed price agreement, Siemens will supply laboratory diagnostic products and services in support of the DHA's healthcare programs through July 2024. As the prime contractor, Siemens will leverage its expertise in diagnostic solutions and partnership with parent company Siemens AG to ensure patient care...